Corporate Snapshot


What We Do

Relevium is a publicly traded corporation strategically focused the acquisition of e-retail brands, products and technologies in the health and wellness market. Relevium’s products are part of the $3.72 trillion dollar global wellness industry — one of the fastest growing worldwide markets. Our specific focus is on products that promote overall health, nutraceuticals, fitness nutrition and cosmeceuticals. The company already has 25 products being sold on Amazon with more being planned.


Who We Are

Relevium’s solid management team combines strong scientific knowledge and marketing know-how. The company leverages this experience to get the best out of the targets they acquire, while developing their own product lines.

The global nutraceutical market is estimated to be over $200 billion USD and is expected to reach $300 billion by the end of 2023.


Relevium also builds partnerships with other firms to expand their product lines. Relevium has recently announced an agreement with Salvenia Nutrition of Montreal and Biodevas Laboratories to develop an exclusive brand and product line of nutraceuticals and phytoceuticals targeted to pet care owners on a direct-to-consumer basis. Relevium has also retained Salvenia, a leading pet and livestock nutrition company, to lead the market research and the product line formulation process.